重组Anti-Alpha-synuclein aggregate抗体[MJFR-14-6-4-2] - BSA and Azide free
Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2] - BSA and Azide free
- RabMAb
- Recombinant
- 了解详情
Be the first to review this product! Submit a review
|
(8 Publications)
Rabbit Recombinant Monoclonal Alpha-synuclein antibody. Carrier free. Suitable for Dot, IHC-P, ICC/IF and reacts with Recombinant fragment - Human, Mouse, Rat, Human samples. Cited in 8 publications.
查看别名
NACP, PARK1, SNCA, Alpha-synuclein, Non-A beta component of AD amyloid, Non-A4 component of amyloid precursor
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2] - BSA and Azide free (AB214033)
Clone MJFR-14-6-4-2 (ab214033) has been successfully conjugated by Abcam. This image was generated using Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2] - Conformation-Specific (Alexa Fluor® 647). Please refer to ab216309 for protocol details.
IHC image of alpha-synuclein aggregate staining in a section of formalin-fixed paraffin-embedded Parkinson human substantia nigra*.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6) in a Biocare Medical NxGen pressure cooker using retrieval settings of 110oC for 8 minutes. Non-specific protein-protein interactions were then blocked in TBS containing 0.025% (v/v) Triton X-100, 0.3M (w/v) glycine and 1% (w/v) BSA for 1h at room temperature. The section was then incubated overnight at +4°C in TBS containing 0.025% (v/v) Triton X-100 and 1% (w/v) BSA with ab216309 at 1/5000 dilution (shown in red) and counterstained using ab195887, Mouse monoclonal to alpha Tubulin (Alexa Fluor® 488), at 1/250 dilution (shown in green). Nuclear DNA was labelled with DAPI (shown in blue). The section was then mounted using Fluoromount®.
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre.
- IHC-Fr
Unknown
Immunohistochemistry (Frozen sections) - Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2] - BSA and Azide free (AB214033)
Clone MJFR-14-6-4-2 (ab214033) has been successfully conjugated by Abcam. This image was generated using Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2] - Conformation-Specific (Alexa Fluor® 488). Please refer to ab216124 for protocol details.
IHC image of alpha-synuclein aggregate staining in a section of frozen Parkinson human substantia nigra*.
The section was fixed using 10% formaldehyde in 1XPBS for 10 minutes. No antigen retrieval step was performed prior to staining. Non-specific protein-protein interactions were then blocked in TBS containing 0.025% (v/v) Triton X-100, 0.3M (w/v) glycine and 1% (w/v) BSA for 1h at room temperature. The section was then incubated overnight at +4°C in TBS containing 0.025% (v/v) Triton X-100 and 1% (w/v) BSA with ab216124 at 1/100 dilution (shown in green) and counterstained using ab195884, Rat monoclonal to Tubulin (Alexa Fluor® 647), at 1/250 dilution (shown in red). Nuclear DNA was labelled with DAPI (shown in blue). The section was then mounted using Fluoromount®.
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre.
- IHC-P
Collaborator
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2] - BSA and Azide free (AB214033)
ab209538 staining Alpha-synuclein aggregate in Human DLB brain tissue sections by Immunohistochemistry (Formalin/PFA fixed paraffin embedded sections). Tissue was fixed with paraformaldehyde and blocked with 2% BSA for 10 minutes at 21°C; antigen retrieval was by heat mediation in Citric acid. Samples were incubated with primary antibody (1/10,000 in TBS) for 2 hours at 21°C. A biotin conjugated anti-rabbit IgG Goat polyclonal was used as the secondary antibody at 1/300 dilution.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab209538).
This image is courtesy of an Abreview submitted by Carl Hobbs
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2] - BSA and Azide free (AB214033)
This ICC/IF data was generated using the same anti-alpha synuclein aggregate antibody clone, MJFR-14-6-4-2, in a different buffer formulation (cat# ab209538).
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.2% Triton X-100 permeabilized ReNcell VM (Human neural progenitor) cells labeling Alpha-synuclein aggregate with ab209538 at 1/5000 dilution, followed by Alexa Fluor® 647 Donkey anti-Rabbit IgG (H+L) secondary antibody at 1/400 dilution (red).
Blocking buffer : 3% bovine serum albumin and 2% fetal bovine serum.
ReNcell VM cells were differentiated in media containing cAMP and GDNF (without bFGF or EGF) and transduced with Ad5C01 viral vector encoding human alpha-synuclein filament (Left image). Right image show control vector cells.
Images were reproduced courtesy of Charles River.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2] - BSA and Azide free (AB214033)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.2% Triton X-100 permeabilized ReNcell VM (Human neural progenitor) cells labeling Alpha-synuclein aggregate with ab209538 at 1/5000 dilution, followed by Alexa Fluor® 647 Donkey anti-Rabbit IgG (H+L) secondary antibody at 1/400 dilution (red).
Upper panel counterstain : Anti-aggregated alpha-synuclein antibody clone 5G4 at 1/400 dilution, followed by AlexaFluor®488 secondary detection (green).
Lower panel counterstain : Anti-alpha/beta-synculein antibody at 1/200 dilution, followed by Alexa Fluor® 488 secondary detection (green).
Blocking buffer : 3% bovine serum albumin and 2% fetal bovine serum.
ReNcell VM cells were differentiated in media containing cAMP and GDNF (without bFGF or EGF) and transduced with Ad5C01 viral vector encoding human WT alpha-synuclein filament.
Images were reproduced courtesy of Charles River.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab209538).
- IHC-P
Collaborator
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2] - BSA and Azide free (AB214033)
This IHC data was generated using the same anti-alpha synuclein aggregate antibody clone, MJFR-14-6-4-2, in a different buffer formulation (cat# ab209538).
ab209538 staining Alpha-synuclein aggregate in rat dorsal root ganglian (DRG) tissue sections by Immunohistochemistry (PFA perfusion fixed frozen sections). Tissue samples were fixed by perfusion with formaldehyde, cut into 20 micron slices and blocked with 2% BSA for 10 minutes at 21°C and antigen retrieval was by heat mediation in citrate buffer. The sample was incubated with primary antibody (1/2000 in TBS/BSA/azide) at 21°C for 2 hours. An Alexa Fluor® 555-conjugated Goat anti-rabbit polyclonal (1/300) was used as the secondary antibody.
This image is courtesy of an Abreview by Carl Hobbs.
- IHC-P
AbReview53483****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2] - BSA and Azide free (AB214033)
ab209538 staining Alpha-synuclein aggregate in mouse colon tissue sections by Immunohistochemistry (PFA perfusion fixed frozen sections). Tissue samples were fixed by perfusion with formaldehyde, cut into 20 micron slices, blocked with 2% BSA for 10 minutes at 21°C and antigen retrieval was by heat mediation in citrate buffer. The sample was incubated with primary antibody (1/2000 in TBS/BSA/azide) at 21°C for 2 hours. A biotin-conjugated goat anti-rabbit polyclonal (1/300) was used as the secondary antibody.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab209538).
This image is courtesy of an Abreview submitted by Carl Hobbs.
- Dot
Supplier Data
Dot Blot - Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2] - BSA and Azide free (AB214033)
Dot blot analysis of alpha-synuclein filament labeled with ab209538 at 2.2 ng/ml.
Lane 1 : Recombinant alpha-synuclein filament treated with 70% formic acid.
Lane 2 : Recombinant alpha-synuclein filament treated with 70% formic acid.
Lane 3 : Untreated recombinant alpha-synuclein filament.
Lane 4 : Untreated recombinant alpha-synuclein filament.
Alpha Synuclein filaments were generated using full length recombinant alpha-synuclein (aa1-140) by incubation in 20mM TRIS, pH 7.2 at 37 °C with agitation.
Denaturation of filaments with 70% formic acid reduces antibody recognition by 30-100 fold, demonstrating conformation specificity.
Data is provided by Professor Poul Henning Jensen, Aarhus University, Denmark.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab209538).
- Dot
Collaborator180918****
Dot Blot - Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2] - BSA and Azide free (AB214033)
Dot Blot showing the reactivity of ab209538 (2 ng/ml) with
F : alpha synuclein Filament
F+FA : alpha synuclein Filament treated in 50% formic acid for 1 h 37oC prior to application to the dot blot.
M+FA : alpha synuclein Monomer treated in 50% formic acid for 1 h 37oC prior to application to the dot blot.
Loading control antibody (1 : 1000) reacts with Alpha-synuclein irrespectively of it being in a filament, oligomer or a monomer.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab209538).
Data is provided by Professor Poul Henning Jensen, Aarhus University, Denmark.
不同偶联物与剂型 (7)
-
Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2] - Conformation-Specific
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2] - Conformation-Specific
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2] - Conformation-Specific
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2]
-
Biotin Anti-Alpha-synuclein aggregate antibody [MJFR-14-6-4-2] - Conformation-Specific
-
Anti-Alpha-synuclein antibody [MJFR-14-6-4-2] - BSA and Azide free (Capture)
反应性数据
产品详情
ab214033 is the carrier-free version of ab209538.
ab214033 is not suitable for WB or other denaturing conditions, as it is conformation-specific.
This antibody is useful for studying Parkinson's disease and other synucleinopathies including dementia with Lewy bodies and multiple system atrophy.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Collaborations
This antibody was developed with support from The Michael J. Fox Foundation.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存条件
推荐的长期储存条件
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Alpha-synuclein manages several cellular processes most notably in neurotransmitter release and vesicle recycling. It does not work alone; it often forms complexes with other proteins like synaptobrevin-2 of the SNARE complex. The formation of these complexes allows for the proper functioning of synaptic vesicles. Alteration in alpha-synuclein's normal function through aggregation disrupts these processes which underlies many neural complications.
Pathways
Many neuronal functions depend on alpha-synuclein's participation in synaptic vesicle pathways. Key pathways include the dopamine metabolic pathway where alpha-synuclein regulates dopamine release. The protein interacts with other synaptic proteins like the SNARE proteins potentially affecting protein kinase pathways. Abnormal aggregation impacts these pathways which can propagate cellular stress and contribute to cellular degeneration.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (8)
Recent publications for all applications. Explore the full list and refine your search
Acta pharmaceutica Sinica. B 15:3092-3106 PubMed40654364
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta neuropathologica 149:41 PubMed40314782
2025
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2410229 PubMed39804980
2025
Applications
Unspecified application
Species
Unspecified reactive species
NPJ Parkinson's disease 10:227 PubMed39613827
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational neurodegeneration 12:40 PubMed37620916
2023
Applications
Unspecified application
Species
Unspecified reactive species
Annals of neurology 92:230-245 PubMed35596947
2022
Applications
Unspecified application
Species
Unspecified reactive species
Neurobiology of disease 161:105543 PubMed34737044
2021
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 4:613 PubMed34021258
2021
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com